IBRX insider transactions
ImmunityBio Inc. (IBRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for IBRX
- Director Simon Barry J. sold $165,306 worth of shares (23,033 units at $7.18) as part of a pre-agreed trading plan, decreasing direct ownership by 0.81% to 2,827,788 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Soon-Shiong Patrick4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Director Simon Barry J. sold $900,788 worth of shares (75,000 units at $12.01), decreasing direct ownership by 3% to 2,850,821 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Director Selecky Christobel exercised 25,000 shares at a strike of $2.98 and sold $250,000 worth of shares (25,000 units at $10.00) (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Officer Soon-Shiong Patrick converted options into 114,329 shares and covered exercise/tax liability with 58,170 shares, increasing direct ownership by 0.19% to 29,757,911 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Chief Financial Officer Sachs David C. converted options into 40,650 shares and covered exercise/tax liability with 20,682 shares, increasing direct ownership by 7% to 300,143 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Chief Accounting Officer Lauer Regan J converted options into 4,065 shares and covered exercise/tax liability with 1,673 shares, increasing direct ownership by 2% to 115,875 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- CEO & President Adcock Richard converted options into 152,439 shares and covered exercise/tax liability with 77,560 shares, increasing direct ownership by 15% to 560,344 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Director Simon Barry J. converted options into 15,243 shares, covered exercise/tax liability with 6,026 shares and sold $1,783,602 worth of shares (175,000 units at $10.19), decreasing direct ownership by 5% to 2,925,821 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Officer Soon-Shiong Patrick converted options into 274,122 shares and covered exercise/tax liability with 118,560 shares, increasing direct ownership by 0.53% to 29,701,752 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Chief Accounting Officer Lauer Regan J converted options into 5,482 shares and covered exercise/tax liability with 2,257 shares, increasing direct ownership by 3% to 113,483 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Chief Financial Officer Sachs David C. converted options into 82,236 shares and covered exercise/tax liability with 42,643 shares, increasing direct ownership by 16% to 280,175 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- CEO & President Adcock Richard converted options into 274,122 shares and covered exercise/tax liability with 140,048 shares, increasing direct ownership by 38% to 485,465 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Director Simon Barry J. sold $1,094,297 worth of shares (151,967 units at $7.20), decreasing direct ownership by 5% to 3,091,604 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Director Selecky Christobel exercised 75,000 shares at a strike of $2.98 and sold $437,650 worth of shares (75,000 units at $5.84) (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Chief Financial Officer Sachs David C. converted options into 30,397 shares and covered exercise/tax liability with 15,435 shares, increasing direct ownership by 7% to 240,582 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- CEO & President Adcock Richard converted options into 34,483 shares and covered exercise/tax liability with 17,510 shares, increasing direct ownership by 5% to 351,391 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Wendel Bruce4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 3 filed by new insider Wendel Bruce3 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Selecky Christobel4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Cohen Cheryl4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Blaszyk Michael D4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Maxwell Linda4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Clark Wesley4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Chief Accounting Officer Lauer Regan J converted options into 4,065 shares and covered exercise/tax liability with 1,669 shares, increasing direct ownership by 2% to 110,258 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Officer Soon-Shiong Patrick covered exercise/tax liability with 42,071 shares and converted options into 114,329 shares, increasing direct ownership by 0.25% to 29,546,190 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Chief Financial Officer Sachs David C. converted options into 40,650 shares and covered exercise/tax liability with 15,860 shares, increasing direct ownership by 12% to 225,620 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- CEO & President Adcock Richard converted options into 152,439 shares and covered exercise/tax liability with 78,167 shares, increasing direct ownership by 29% to 334,418 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Director Simon Barry J. converted options into 15,243 shares and covered exercise/tax liability with 5,453 shares, increasing direct ownership by 0.30% to 3,243,571 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Officer Soon-Shiong Patrick4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Chief Accounting Officer Lauer Regan J4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Sachs David C.4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by CEO & President Adcock Richard4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Director Simon Barry J. exercised 110,020 shares at a strike of $2.00, increasing direct ownership by 4% to 3,233,781 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- CEO & President Adcock Richard converted options into 34,483 shares and covered exercise/tax liability with 17,475 shares, increasing direct ownership by 7% to 260,146 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Chief Financial Officer Sachs David C. converted options into 30,397 shares and covered exercise/tax liability with 15,405 shares, increasing direct ownership by 8% to 200,830 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Chief Accounting Officer Lauer Regan J converted options into 21,031 shares and covered exercise/tax liability with 7,503 shares, increasing direct ownership by 14% to 107,862 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Officer Soon-Shiong Patrick converted options into 117,185,260 shares (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Brennan John Owen4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Clark Wesley4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Cohen Cheryl4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Selecky Christobel4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Blaszyk Michael D4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Director Maxwell Linda4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Lauer Regan J4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Simon Barry J.4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Sachs David C.4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Adcock Richard4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Soon-Shiong Patrick4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Adcock Richard converted options into 83,334 shares and covered exercise/tax liability with 43,165 shares, increasing direct ownership by 20% to 243,138 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Simon Barry J. converted options into 57,200 shares and covered exercise/tax liability with 22,094 shares, increasing direct ownership by 1% to 3,123,761 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Sachs David C. converted options into 70,745 shares and covered exercise/tax liability with 26,835 shares, increasing direct ownership by 31% to 185,838 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Lauer Regan J converted options into 32,872 shares and covered exercise/tax liability with 13,470 shares, increasing direct ownership by 26% to 94,334 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4 filed by Soon-Shiong Patrick4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Sachs David C. converted options into 30,397 shares and covered exercise/tax liability with 10,511 shares, increasing direct ownership by 16% to 141,928 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Adcock Richard converted options into 34,483 shares and covered exercise/tax liability with 17,096 shares, increasing direct ownership by 9% to 202,969 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- Lauer Regan J converted options into 21,030 shares, increasing direct ownership by 39% to 74,932 units (SEC Form 4)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4: Soon-Shiong Patrick acquired $269,986,597 worth of shares (209,291,936 units at $1.29)4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4: Sachs David C. converted options into 70,744 shares, increasing direct ownership by 138% to 122,042 units4 - ImmunityBio, Inc. (0001326110) (Issuer)
- SEC Form 4: Lauer Regan J converted options into 32,872 shares, increasing direct ownership by 156% to 53,902 units4 - ImmunityBio, Inc. (0001326110) (Issuer)